Have you even read the FDA Pathways that the BOD is trying to go down? 10 years? In your dreams. You clearly know very little in detail about the company.
And the value that can be created purely on progressing clinical assets especially if we are listed on the NYSE/NASDAQ will dwarf any valuation from a typical pot stonk.
Yet alone our psychedelics endeavours.
Cant believe this kind of dribble lol Go back to CPH or AGH or any of those types
